Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support

RecruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

September 27, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Hematologic DiseasesBone Marrow TransplantationHematopoietic Stem Cell Transplantation
Interventions
DEVICE

NewSpringForMe digital solution

Follow-up of transplanted patients for hematological diseases using the NewSpringForMe device as support of quality of life

Trial Locations (1)

75010

RECRUITING

Service Hématologie Greffe Trèfle 3, Hôpital Saint-Louis, AP-HP, Paris

All Listed Sponsors
collaborator

Saint-Louis Hospital, Paris, France

OTHER

collaborator

Nutricia Nutrition Clinique

INDUSTRY

collaborator

Clinicprosport

UNKNOWN

collaborator

ELLYE

UNKNOWN

collaborator

Association Aïda

UNKNOWN

collaborator

Gilead Sciences

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Groupe Apicil

UNKNOWN

collaborator

Association Laurette Fugain

UNKNOWN

collaborator

Fondation du LEEM

UNKNOWN

collaborator

Fondation AFNIC

UNKNOWN

collaborator

Pierre Fabre Medicament

INDUSTRY

collaborator

Novartis Pharmaceuticals

INDUSTRY

collaborator

University Hospital, Clermont-Ferrand

OTHER

collaborator

LAPSCO, Université Clermont-Auvergne

UNKNOWN

lead

Fonds de Dotation HTC Project

OTHER